Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Six-Month Follow-up Chest CT findings after Severe COVID-19 Pneumonia

(2021) Xiaoyu Han et al.   RADIOLOGY

Persistent Symptoms in Patients After Acute COVID-19

(2020) Angelo Carfì et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19

(2020) Wenhui Huang et al.   JOURNAL OF INFECTION

A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations

(2020) Aditi S Shah et al.   THORAX

Imaging Patterns are Associated with Interstitial Lung Abnormality Progression and Mortality

(2019) Rachel K Putman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Telomere Length Changes during Critical Illness: A Prospective, Observational Study

(2019) Zribi et al.   Genes

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation

(2014) Bridget D Stuart et al.   Lancet Respiratory Medicine

Chest CT Features are Associated With Poorer Quality of Life in Acute Lung Injury Survivors*

(2012) Ellen L. Burnham et al.   CRITICAL CARE MEDICINE

Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis

(2008) Jennifer T. Cronkhite et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE